Navigation Links
Endocare Reports 2008 First Quarter Financial Results
Date:5/1/2008

7.9 Percent Year-Over-Year Increase in Revenue; Gross Margin Increase

Continues; Net Losses Decline

IRVINE, Calif., May 1 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today reported solid growth in revenues, cryoprobe sales and procedures and continued expense reductions in the three months ended March 31, 2008, resulting in a 48.1 percent reduction in net loss compared to the first quarter of 2007.

For the first quarter of 2008, total revenues were $8.1 million, up 7.9 percent from $7.5 million in the first quarter of 2007 and up sequentially 17.8 percent from the $6.9 million in the fourth quarter of 2007. Cryoprobe sales in the 2008 first quarter totaled 12,203, an 8.8 percent increase from the 11,211 sold in the first quarter of 2007. The estimated number of domestic cryoablation procedures performed was 2,568, up from 2,315 in the prior-year period.

Endocare Chairman, CEO and President Craig T. Davenport said, "We were pleased with the solid growth we achieved in the first quarter of 2008 over what was a strong first quarter last year. Our sales force continues to report steady progress in its sales activities with prospective physician customers. We believe this is due in part to the continuing publication of clinical research, media coverage of cryoablation and increased physician attention on focal cryoablation at numerous focal cryoablation conferences held around the United States by prestigious medical institutions during the first quarter." Davenport continued, "The launch of our variable cryoprobe, or V-Probe, technology has been received enthusiastically by existing and prospective physicians due in part to the potentially significant advantages that the V-Probe offers. Providing one probe that can create five different-sized isotherms offers the ability to indi
'/>"/>

SOURCE Endocare, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
2. LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase
3. Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
4. Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine
5. Alexion Reports First Quarter 2008 Results
6. Masimo Reports First Quarter 2008 Financial Results
7. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
8. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
9. SuperGen Reports 2008 First Quarter Financial Results
10. Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
11. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... ... The next-generation sequencing (NGS) clinical market is poised for huge growth as it ... reveals in its new report that the market drivers of this vibrant industry include ... better diagnostics as part of a molecular diagnostics trend. , The global market is ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan contest will ask ... to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will ... and a period of expert mentorship from a senior industry figure drawn from the ...
(Date:6/30/2015)... R-Japan Co.,Ltd. obtained the license of cell processing facility under ... Ministry of Health, Labour and Welfare Kinki Bureau of Health ... fact that R- Japan received the license ... Medical Devices Agency (PMDA) on May 18, 2015 two months ... manufacturing service to medical institutions. As of November 25, 2014, ...
(Date:6/30/2015)... 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ... therapeutics that address unmet medical needs in women,s ... will present at the Cantor Fitzgerald Inaugural ... 2015Time: , 4:45 PM EDTLocation: , Le Parker ... , www.juniperpharma.com, under  ,Investor, or  click ...
Breaking Biology Technology:NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2
... July 20 Volcano Corporation (Nasdaq: VOLC ), a leading ... the diagnosis and treatment of coronary and peripheral vascular disease, today announced ... first six months of fiscal 2010 on Friday, July 30 . ... The company will hold ...
... -- Tomorrow,s television and computer screens could be brighter, ... process developed by a team of researchers from Canada ... The synthesis of a conjugated organic polymer--widely used ... televisions and solar cells--could mean more efficient, cheaper electronics. ...
... MONTREAL and HONG KONG, China , July 19 ... from the Phase 1 portion of its Phase 1-2 Study of ... patients with advanced hepatocellular carcinoma (primary liver cancer). , ... This study, entitled "A Phase ...
Cached Biology Technology:Volcano Corporation Schedules Second Quarter Conference Call, Webcast 2Polymer synthesis could aid future electronics 2Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma 2Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma 3
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/25/2015)... 2015  Imagine a tool specifically designed to help ... life. That,s exactly what USANA,s True Health Assessment ... portable health program provides a personalized approached to measuring ... your lifestyle and nutrition. At the ... night, USANA,s THA was honored with the Industry Innovation ...
(Date:6/24/2015)... DUBLIN , June 22, 2015 ... has announced the addition of the "Huawei ... Analysis" report to their offering. ... going to the opposite direction than Apple,s and ... innovative fingerprint sensor developed by Fingerprint Cards, a ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... stomach detects and tells our brains how full we are becomes ... they lose weight, according to new research from the University ... reason why most people who lose weight on a diet eventually ... Adelaide PhD student Stephen Kentish investigated the impact of a high-fat ...
... coast region, fresh spinach is a high-production, high-value ... fertilizer and irrigation to ensure ideal growth, and ... defining deep green color. These production practices -- ... crop,s intensive production cycle -- can increase the ...
... 2013 Fighting hereditary disease among Jews is the ... called JScreen.  The JScreen program ( www.jscreen.org ), managed ... Genetics, provides at-home genetic screening and private counseling for ... hereditary diseases that could be passed to their children. ...
Cached Biology News:Obese stomachs tell us diets are doomed to fail 2Study recommends strategies for improved management of fresh market spinach 2JScreen public health initiative launches to fight Jewish genetic diseases 2JScreen public health initiative launches to fight Jewish genetic diseases 3